Home

Margo R Roberts

CIK 1609643 · Chief Scientific Officer · last filed 2024-06-21

Margo R Roberts is a Chief Scientific Officer who has filed 21 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing, for UBX, was dated Jun 21, 2024. Across all open-market trades the lifetime net is −$6.9M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

21

Lifetime Open-Market Net

-$6.91M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Unity Biotechnology, Inc. (UBX) Delisted Director — $0.20 — $0 7 2024-06-21
Kite Pharma, Inc. (KITE) Delisted Chief Scientific Officer 11,346 — — -$6.91M 14 2016-03-17

Recent Filings

21 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-06-21 Unity Biotechnology, Inc. (UBX) Delisted Grant (A) — $0 EDGAR
2023-06-26 Unity Biotechnology, Inc. (UBX) Delisted Grant (A) — $0 EDGAR
2022-06-27 Unity Biotechnology, Inc. (UBX) Delisted Grant (A) — $0 EDGAR
2021-06-28 Unity Biotechnology, Inc. (UBX) Delisted Grant (A) — $0 EDGAR
2020-06-22 Unity Biotechnology, Inc. (UBX) Delisted Grant (A) — $0 EDGAR
2019-06-24 Unity Biotechnology, Inc. (UBX) Delisted Grant (A) — $0 EDGAR
2018-12-04 Unity Biotechnology, Inc. (UBX) Delisted Grant (A) — $0 EDGAR
2016-03-17 Kite Pharma, Inc. (KITE) Delisted Mixed — -$362.4K EDGAR
2016-03-17 Kite Pharma, Inc. (KITE) Delisted Exer (M) +9,632 $23.2K EDGAR
2016-02-19 Kite Pharma, Inc. (KITE) Delisted Mixed — -$427.3K EDGAR
Showing 1–10 of 21
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.